According to a new report, published by KBV research, The Global Pharmaceutical Drug Delivery Market size is expected to reach $1.9 trillion by 2030, rising at a market growth of 4.1% CAGR during the forecast period.
The Injectable Drug Delivery segment is leading the Global Pharmaceutical Drug Delivery Market, by Route of Administration in 2022 thereby, achieving a market value of $711.8 Billion by 2030. Injectable formulations often lead to higher bioavailability compared to oral administration. This is because the drug directly enters the bloodstream, bypassing the digestive system and potential degradation. This can be particularly crucial for drugs with low oral bioavailability. Injectable drug delivery can enhance patient compliance by eliminating the need for frequent dosing. Long acting injectables reduce the burden on patients and healthcare providers, leading to better adherence to treatment plans.
The Diabetes segment is experiencing a CAGR of 5.4% during (2023 - 2030). Drug delivery technologies address drug solubility and bioavailability challenges, ensuring optimal absorption of diabetes medications. This contributes to improved glycemic control and better management of diabetes. Drug delivery technologies facilitate the administration of combination therapies, allowing multiple drugs in a single formulation. This approach addresses different aspects of diabetes pathophysiology for enhanced efficacy.
Full Report: https://www.kbvresearch.com/pharmaceutical-drug-delivery-market/
The North America region dominated the Global Pharmaceutical Drug Delivery Market, by Region in 2022 thereby, achieving a market value of $717 Billion by 2030, growing at a CAGR of 3.4 % during the forecast period. The Europe region would witness a CAGR of 3.7% during (2023 - 2030). Additionally, The Asia Pacific region is experiencing a CAGR of 4.9% during (2023 - 2030).
By Route of Administration
By Application
Unique Offerings 
